A SIMPLE KEY FOR J9271 - INJ PEMBROLIZUMAB UNVEILED

This prevents the activation of the T-cell which Typically would target and demolish cancer. The cancer cells can then multiply and distribute. When Keytruda binds into the PD-1 receptor it stops cancer cells from linking to and inactivating T-cells, letting T-cell re-activation, and boosting the immune system's response against cancer. This affect